Analysis of single nucleotide polymorphisms (SNPs) of the small-conductance calcium activated potassium channel (SK3) gene as genetic modifier of the cardiac phenotype in myotonic dystrophy type 1 patients

Acta Myologica

Volumn 27, Issue DEC., 2008, Pages 82-89

  Rinaldi, F ^a   Botta, A ^a   Vallo, L ^a   Contino, G ^a   Morgante, A ^a   Iraci, R ^a   Catalli, C ^d   Silvestri, G ^c   Ventriglia, V M ^b   Politano, L ^b   Novelli, Giuseppe ^a,d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Association study; Cardiac phenotype; K3; Myotonic dystrophy; SNPs

Indexed keywords

ADENINE; BETA 2 MICROGLOBULIN; DNA FRAGMENT; GUANINE; MESSENGER RNA; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; DNA MODIFICATION; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEART MUSCLE CONDUCTION DISTURBANCE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUSCLE BIOPSY; MYOTONIC DYSTROPHY; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRINUCLEOTIDE REPEAT;

ADULT; ATRIOVENTRICULAR BLOCK; BIOPSY; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, MESSENGER; SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS;

EID: 64949107173     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Harper PS. Myotonic dystrophy. 3rd ed. London: WB Saunders 2001.
2. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992; 69:385.
3. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18.
4. Harper PS. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press 2004.
5. Pelargonio G, Dello Russo A, Sanna T, et al. Myotonic dystrophy and the heart. Heart 2002;88:665-70.
6. de Die-Smulders CEM, Hweler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain 1998;121:1557-63.
7. Prystowsky EN, Pritchett EL, Roses AD, et al. The natural history of conduction system disease in myotonic muscular dystrophy as determined by serial electrophysiologic studies. Circulation 1979;60:1360-4.
8. Florek RC, Triffon DW, Mann DE, et al. Electrocardiographic abnormalities in patients with myotonic dystrophy. West J Med 1990;153:24-7.
9. Hawley RJ, Milner MR, Gottdiener JS, et al. Myotonic heart disease: a clinical follow-up. Neurology 1991;41:59-62.
10. Fragola PV, Autore C, Magni G, et al. The natural course of cardiac conduction disturbances in myotonic dystrophy. Cardiology 1991;79:93-8.
11. Fragola PV, Luzi M, Calo L, et al. Cardiac involvement in myotonic dystrophy. Am J Cardiol 1994;74:1070-2.
12. Philips AV, Timchenko LT, Cooper TA. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998;280:737-41.
13. Merino JL, Carmona JR, Fernández-Lozano I, et al. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation 1998;98:541-6.
14. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Med 2008;358:2688-97.
15. Hawley RJ, Gottdiener JS, Gay JA, et al. Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med 1983;143:2134-6.
16. Hiromasa S, Ikeda T, Kubota K. A family with myotonic dystrophy associated with diffuse cardiac conduction disturbances as demonstrated by His bundle electrocardiography. Am Heart J 1986;111:85-91.
17. Melillo G, Ruggieri MP, Magni G, et al. Malignant cardiac involvement in a family with myotonic dystrophy. G Ital Cardiol 1996;26:853-61.
18. Vergara C, Latorre R, Marrion NV, et al. Review.
19. Meech RW. Calcium-dependent potassium activation in nervous tissues. Annu Rev Biophys Bioeng 1978;7:1-18.
20. Pallotta BS, Magleby KL, Barrett JN. Single channel recordings of Ca2+-activated K+ currents in rat muscle cell culture. Nature 1981;293:471-4.
21. Sah P. Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation. Trends Neurosci 1996;19:150-4.
22. Xia XM, Fakler B, Rivard A, et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 1998;395:503-7.
23. Köhler M, Hirschberg B, Bond CT, et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science 1996;273:1709-14.
24. Schmid-Antomarchi H, Renaud JF, Romey G, et al. The all-or-none role of innervation in expression of apamin receptor and of apamin-sensitive Ca2+-activated K+ channel in mammalian skeletal muscle. Proc Natl Acad Sci USA 1985;82:2188-91.
25. Jacobson D, Herson PS, Neelands TR, et al. SK channels are necessary but not sufficient for denervation-induced hyperexcitability. Muscle Nerve 2002;26:817-22.
26. Favero M, Jiang DJ, Chiamulera C, et al. Expression of small-conductance calcium-activated potassium channels (SK3) in skeletal muscle: regulation by muscle activity. J Physiol 2008;586:4763-74.
27. Renaud JF, Schmid A. Biochemical and pharmacologic properties of the Ca2+ channel of skeletal muscle: appearance during myogenesis and the relation between its structure and function. J Physiol (Paris) 1986;81:177-84.
28. Kimura T, Takahashi MP, Okuda Y, et al. The expression of ion channel mRNAs in skeletal muscles from patients with myotonic muscular dystrophy. Neurosci Lett 2000;295(3):93-6.
29. Behrens MI, Jalil P, Serani A, et al. Possible role of apamin-sensitive K+ channels in myotonic dystrophy. Muscle Nerve 1994;17:1264-70.
30. Stocker M. Ca(2+)-activated K+ channels: molecular determinants and function of the SK family. Nat Rev Neurosci 2004;5:758-70.
31. Dracopoli NC, Bruns GA, Brodeur GM, et al. Report and abstracts of the First International Workshop on Human Chromosome 1 Mapping 1994. Bethesda, MA, USA, March 25-27, 1994. Cytogenet Cell Genet 1994;67:144-65.
32. www.eurobiobank.org
33. Bonifazi E, Vallo L, Giardina E, et al. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn Mol Pathol 2004;13:164-6.
34. Novelli G, Gennarelli M, Menegazzo E, et al. (CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy patients. Biochem Med Metab Biol 1993;50:85-92.
35. Lazarus A, Varin J, Ounnoughene Z, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999;99:1041-6.
36. Kimura T, Takahashi MP, Fujimura H, et al. Expression and distribution of a small-conductance calcium-activated potassium channel (SK3) protein in skeletal muscles from myotonic muscular dystrophy patients and congenital myotonic mice. Neurosci Lett 2003;347:191-5.
37. Tuteja D, Xu D, Timofeyev V, Lu L et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes Am J Physiol Heart Circ Physiol. 2005;289:H2714-23.
38. Xu Y, Tuteja D, Zhang Z, et al. Molecular identification and functional roles of a Ca(2+)-activated K+ channel in human and mouse hearts. J Biol Chem 2003;278:49085-94.
39. Tomita H, Shakkottai VG, Gutman GA, et al, Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophrenia. Mol Psychiatry 2003;8:524-35,460.
40. Kolski-Andreaco A, Tomita H, Shakkottai VG, et al. SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels. J Biol Chem 2004;279:6893-904.
41. Akazawa H, Komuro I. Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases. Pharmacol Ther 2005;107:252-68.
42. Yadava RS, Frenzel-McCardell CD, Yu Q, et al. RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Nat Genet 2008;40:61-8.